Gemcabene (PD-72953) is a first-in-class lipid-lowering agent that reduces low-density lipoprotein cholesterol (LDL-C) and triglycerides, increases high-density lipoprotein cholesterol (HDL-C), and lowers pro-inflammatory acute-phase proteins such as C-reactive protein (CRP), demonstrating anti-inflammatory activity; it also significantly downregulates hepatic mRNA markers involved in inflammation (TNF-α, MCP-1, MIP-1β, CCR5, CCR2, NF-κB), lipogenesis and lipid modulation (ApoC-III, ACC1, ADH-4, Sulf-2), and fibrosis (TIMP-1 and MMP-2).